Dr. Julia Elizabeth Ballard, MD

Dr. Ballard practices at City of Hope Cancer Center Atlanta in Newnan, Georgia, part of City of Hope.

Dr. Ballard's NPI, 1053409201, was assigned on October 11, 2006. Dr. Ballard graduated from Emory University School of Medicine in 1979. Dr. Ballard holds Georgia license 21637.

Dr. Ballard's primary practice is City of Hope Cancer Center Atlanta, at 600 Celebrate Life Parkway North, Newnan, GA 30265 in Coweta County. The practice phone is (404) 844-8334.

Dr. Ballard's primary practice is City of Hope Cancer Center Atlanta in Newnan, Georgia, part of City of Hope. Dr. Ballard is also affiliated with Piedmont Newnan Hospital. The medical group on file is City of Hope Atlanta. Dmand AI also links Dr. Ballard to 1 more hospital and 3 medical groups, each named with a free account. Dr. Ballard's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ballard practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ballard's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ballard is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Ballard is licensed in Georgia.

CMS data shows 115 Medicare services from Dr. Ballard across 3 procedure codes in 2024, all of them office visits, for 115 Medicare patients. Medicare paid $8,859 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 115 Medicare patients who saw Dr. Ballard in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 73% have cancer. 15% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ballard's median patient age at 70, with 55% women.

In 2024, Dr. Ballard wrote 107 Medicare Part D claims for 77 patients. 93% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $88 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Ballard for performance year 2024, reported as part of a group. Dr. Ballard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Ballard from 3 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 100% of the total. Baxter Healthcare paid the most, $17.

Dr. Ballard graduated from Emory University School of Medicine in 1979.